Literature DB >> 324669

In vitro effect of transfer factor on active rosettes and leucocyte migration of patients with cancer.

K Nékám, L Kalmár, P Gergely, G Kelemen, B Fekete, I Láng, J Lévai, G Y Petrányi.   

Abstract

The in vitro effect of transfer factor (TF) and its obtained by gel filtration was studied on the active rosettes and leucocyte migration inhibition. TF and one fraction (IV) restored the reactivity of lymphocytes from tumour-bearing patients to tuberculin and Candida antigens in the leucocyte migration assay. TF and fraction IV was also found to enhance the number of active rosettes of tumour-bearing patients, whereas no such effect was observed on lymphocytes of patients with active SLE or controls.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 324669      PMCID： PMC1540949     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


  16 in total

1.  Restorative effect of normal human serum, transfer factor and thymosin on the ability of heated human lymphocytes to form rosettes with sheep erythrocytes.

Authors:  N F Mendes; P J Saraiva; O B Santos
Journal:  Cell Immunol       Date:  1975-06       Impact factor: 4.868

2.  Spontaneous and PHA-induced rosetting of human blood, tonsil lymphocytes and MLC blasts with sheep, human and horse erythrocytes.

Authors:  P Gergely; F Vanky; E Klein
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

3.  Restoration of T-lymphocyte deficiency with dialysable leucocyte extract.

Authors:  H Valdimarsson; G Hambleton; K Henry; I McConnell
Journal:  Clin Exp Immunol       Date:  1974-02       Impact factor: 4.330

4.  Rosette-forming cells, immunologic deficiency diseases and transfer factor.

Authors:  J Wybran; A S Levin; L E Spitler; H H Fudenberg
Journal:  N Engl J Med       Date:  1973-04-05       Impact factor: 91.245

5.  In vitro transfer of cellular immunity against nasopharyngeal carcinoma using transfer factor from donors with Epstein-Barr virus antibody activity.

Authors:  L J Brandes; G J Goldenberg
Journal:  Cancer Res       Date:  1974-11       Impact factor: 12.701

Review 6.  Transfer factor.

Authors:  H S Lawrence
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

7.  The "active" rosette test in immunodeficiency diseases.

Authors:  S Horowitz; T Groshong; R Albrecht; R Hong
Journal:  Clin Immunol Immunopathol       Date:  1975-09

8.  Effect of transfer factor therapy on mixed lymphocyte culture reactivity.

Authors:  B Dupont; M Ballow; J A Hansen; C Quick; E J Yunis; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

9.  Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.

Authors:  J Wybran; H H Fudenberg
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

10.  Human T lymphocyte "E" rosette function. I. A process modulated by intracellular cyclic AMP.

Authors:  F V Chisari; T S Edgington
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307
View more
  2 in total

1.  Active E rosette formation by human lymphoblasts.

Authors:  G Semenzato; G Amadori; P Sarasin; G Gasparotto
Journal:  Immunology       Date:  1978-04       Impact factor: 7.397

2.  Rosette-increasing factor released by PHA-stimulated mononuclear cells in vitro which augments active E and EA rosette formation.

Authors:  M Kubota; T Yoshida; K Shinomiya; H Mikawa
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.